文献速递临床试验与 GCP

低剂量静脉肝素治疗动脉瘤性蛛网膜下腔出血:随机对照临床试验方案

Effects of low-dose intravenous heparin therapy in aneurysmal subarachnoid hemorrhage: a randomized controlled clinical trial protocol.
PubMed 文献 · Trials · 2023-07-08

本研究为开放标签、单中心、随机对照试验,计划招募456例动脉瘤性蛛网膜下腔出血患者,每组228例,比较静脉普通肝素与皮下低分子量肝素注射的临床结局,主要结局为脑血管痉挛。

要点

  • 开放标签、单中心、随机对照试验,计划纳入456例,每组228例。
  • 主要结局为脑血管痉挛;次要结局包括出血事件、缺血事件、肝素诱导的血小板减少症等。
  • 研究方案已获深圳市宝安区人民医院伦理委员会批准(批件号BYL20220805)。

核心结论

  • 研究旨在比较动脉瘤栓塞术后静脉普通肝素与皮下低分子量肝素注射两种方案相关的临床结局。

研究设计与样本

  • 开放标签、单中心、随机对照临床试验方案,计划招募456例患者,每组228例。
  • 研究方案已获深圳市宝安区人民医院伦理委员会批准(批件号BYL20220805),临床试验注册号NCT05696639,注册日期2023年3月30日。

关键数值与推荐

  • 主要结局为脑血管痉挛;次要结局包括出血事件、缺血事件、肝素诱导的血小板减少症、深静脉血栓形成、脑静脉循环时间、脑水肿评分和脑积水发生率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin anticoagulation therapy is a widely used method to prevent cerebral vasospasm (CV) and venous thrombosis in patients with subarachnoid hemorrhage caused by ruptured cerebral aneurysms. Subcutaneous heparin injection is considered safe and effective, whereas continuous intravenous heparin infusion is still being debated due to the risk of bleeding. Although most retrospective studies have confirmed the safety and effectiveness of unfractionated heparin (UFH) after aneurysm embolization therapy and its ability to reduce CV, there is still no randomized clinical trial comparing UFH and subcutaneous low-molecular-weight heparin (LMWH) injection in this population. Therefore, this study aims to compare the clinical outcomes associated with these two treatment approaches. METHODS: The study is an open-label, single-center, randomized controlled trial and aims to recruit 456 patients, with 228 patients in each group. The primary outcome was CV; the second outcomes measures are occurrence of bleeding events, ischemic events, heparin-induced thrombocytopenia, deep vein thrombosis, cerebral venous circulation time, brain edema score, and hydrocephalus incidence. ETHICS AND DISSEMINATION: This study protocol obtained ethical approval from the Ethics Committee of Baoan People's Hospital, Shenzhen, Guangdong (approval number: BYL20220805). This work will be published in peer-reviewed international medical journals and presented at medical conferences. TRIAL REGISTRATION: ClinicalTrials ID: NCT05696639. Registered on March 30, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Hu J. Effects of low-dose intravenous heparin therapy in aneurysmal subarachnoid hemorrhage: a randomized controlled clinical trial protocol. Trials. 2023. PMID: 37422666. doi:10.1186/s13063-023-07493-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。